Literature DB >> 23432692

Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.

N Arandi1, A Mirshafiey, H Abolhassani, M Jeddi-Tehrani, R Edalat, B Sadeghi, M Shaghaghi, A Aghamohammadi.   

Abstract

Common variable immunodeficiency (CVID) is the most symptomatic primary antibody deficiency associated with recurrent infections and chronic inflammatory diseases as well as autoimmunity. CD4(+) CD25(+) FOXP3(+) regulatory T cells (Tregs) are critical T cell subsets for maintaining self-tolerance and regulation of immune response to antigens thus play a pivotal role in preventing autoimmunity. Thirty-seven CVID patients and 18 age-/sex-matched controls were enrolled. Peripheral blood mononuclear cells (PBMCs) were obtained from both groups, and the percentage of Tregs was calculated using flow cytometry method. The mRNA expression of Tregs' surface markers cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and glucocorticoid-induced tumour necrosis factor receptor (GITR), which are associated with Tregs' inhibitory function, was compared between patients and controls by quantitative real-time PCR TaqMan method. The results revealed that the frequency of Tregs was significantly lower in CVID patients than normal individuals (P < 0.001). In addition, CVID patients with autoimmunity were found to have markedly reduced proportion of Tregs compared to those cases without autoimmune diseases (P = 0.023). A significant difference was seen in factor forkhead box P3 (FOXP3) expression between CVID patients and controls (P < 0.001). The mRNAs of CTLA-4 and GITR genes were expressed at lower levels in CVID patients compared to control group (P = 0.005 and <0.001, respectively). Our findings showed reduced proportion of Tregs in CVID patients together with downregulation of FOXP3 protein and diminished expression of inhibitory Tregs' markers. It could be concluded that all of these changes may be responsible for cellular immune dysregulation observed in these patients especially those with autoimmune manifestation.
© 2013 The Authors. Scandinavian Journal of Immunology © 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432692     DOI: 10.1111/sji.12040

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  16 in total

Review 1.  Spectrum of Phenotypes Associated with Mutations in LRBA.

Authors:  Omar K Alkhairy; Hassan Abolhassani; Nima Rezaei; Mingyan Fang; Kasper Krogh Andersen; Zahra Chavoshzadeh; Iraj Mohammadzadeh; Mariam A El-Rajab; Michel Massaad; Janet Chou; Asghar Aghamohammadi; Raif S Geha; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

2.  CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Authors:  Necil Kutukculer; Elif Azarsiz; Guzide Aksu; Neslihan Edeer Karaca
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

Review 3.  Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.

Authors:  Paul J Maglione
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

4.  Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.

Authors:  Peter S Kim; Caroline Jochems; Italia Grenga; Renee N Donahue; Kwong Y Tsang; James L Gulley; Jeffrey Schlom; Benedetto Farsaci
Journal:  J Immunol       Date:  2014-02-10       Impact factor: 5.422

Review 5.  Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency.

Authors:  Paul J Maglione; Montserrat Cols; Charlotte Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-05       Impact factor: 4.806

Review 6.  Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.

Authors:  Simona Ronchetti; Erika Ricci; Maria Grazia Petrillo; Luigi Cari; Graziella Migliorati; Giuseppe Nocentini; Carlo Riccardi
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

7.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

Review 8.  T-cell abnormalities in common variable immunodeficiency: the hidden defect.

Authors:  Gabriel K Wong; Aarnoud P Huissoon
Journal:  J Clin Pathol       Date:  2016-05-06       Impact factor: 3.411

Review 9.  Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity.

Authors:  Jessica D Gereige; Paul J Maglione
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

10.  Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune Encephalitis.

Authors:  Matthias Froehlich; Eva C Schwaneck; Michael Gernert; Ottar Gadeholt; Patrick-Pascal Strunz; Henner Morbach; Hans-Peter Tony; Marc Schmalzing
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.